Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Medical Devices ETF (Symbol: IHI) where we have detected an approximate $68.0 million dollar inflow -- that's a 1.4% increase week ove
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Preferred and Income Securities ETF (Symbol: PFF) where we have detected an approximate $193.1 million dollar inflow -- that's a 1.1% incre
One of last year's biggest broken IPOs was Uber (NYSE: UBER), which shed a little more than a third of its value in 2019 after hitting the market at $45 in its springtime IPO. It's been driving in the right direction this year, up 39% through Wednesday's close.
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core Total USD Bond Market ETF (Symbol: IUSB) where we have detected an approximate $68.7 million dollar inflow -- that's a 1.6% increase w
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $74.9 million dollar inflow -- that's a 0.3% increase week over week i
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The following are today's upgrades for Validea's Patient Investor model based on the published strategy of Warren Buffett. This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.
Ardsley, NY-based Acorda Therapeutics, Inc. ACOR is focused on developing novel treatments that improve neurological function in people suffering from various types of nervous system disorders.
Zacks
Checked
22 minutes 45 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets